Northwest Compounders Achieves PCAB Accreditation
As of June 2023, Northwest Compounders is officially accredited by the Accreditation Commission of Health Care (ACHC) for sterile and non-sterile compounding under their PCAB (Pharmacy Compounding Accreditation Board) program.
The FDA’s GFI #256 Implementation Date is Approaching, Here is What You Need to Know
We have been closely monitoring the development of GFI #256 since its announcement last year and would like to provide all of our partners with an up-to-date overview of what this means for the veterinary industry.
A Critical Update on the FDA’s GFI #256: Compounding Animal Drugs from Bulk Drug Substances
A new draft guidance from the FDA that would shape the way compounded medicines are produced and prescribed for animals hit the stage back in 2019.
Northwest Compounders Accelerates Growth with Major New Production Facility
The state-of-the-art facility features a 5,000-square-foot compounding lab that will enable the company to significantly expand operations.
Not Just an Ordinary Pharmacy Student Internship: Northwest Compounders’ Pharmacy Student Internship Program
We are grateful for the opportunity to educate the next generation of pharmacists in compounding.
Quality in the Compounding Industry: A Deep Dive Into What Quality Actually Means and How to Achieve It
Compounding pharmacies all over the U.S. claim to offer high quality products, but what does “high quality” truly mean and why is it significant?
The Veterinary Technician’s Guide to Compounding
Vet techs play a vital role in veterinary medicine and also serve as a critical medium between veterinarians and compounding pharmacies.
Preparing for the Implementation of the FDA’s Ground Shaking New Requirements for Compounded Pet Medications
The niche market of veterinary compounding has largely remained undisturbed, until now.
